The effect of statin therapy on lipoprotein associated phospholipase A2 levels

This publication has 21 references indexed in Scilit:

• Lipoprotein-Associated Phospholipase A ₂ Adds to Risk Prediction of Incident Coronary Events by C-Reactive Protein in Apparently Healthy Middle-Aged Men From the General Population
  Circulation, 2004
• Lipoprotein-Associated Phospholipase A ₂ , High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study
  Circulation, 2004
• Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular disease
  Current Opinion in Lipidology, 2003
• Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteins
  Journal of Lipid Research, 2003
• Lp-PLA2: an emerging biomarker of coronary heart disease
  Expert Review of Molecular Diagnostics, 2002
• Effect of Statin Therapy on C-Reactive Protein Levels
  JAMA, 2001
• Lipoprotein-Associated Phospholipase A₂as an Independent Predictor of Coronary Heart Disease
  New England Journal of Medicine, 2000
• Inhibitory effect of interleukin-8 on the secretion of platelet-activating factor acetylhydrolase by human decidual macrophages
  Journal of the Society for Gynecologic Investigation, 1999
• Identification of the G994 → T missense mutation in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men
  Metabolism, 1998
• Effects of endotoxins and cytokines on the secretion of platelet-activating factor-acetylhydrolase by human decidual macrophages
  American Journal of Obstetrics and Gynecology, 1993